Daniel A. Low
University of California, Los Angeles
ORCID: 0000-0002-6425-9228Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer”.
Percy Lee, Daniel A. Low, Joshua Kim, Kathryn E. Mittauer, M. Bassetti +25 more
Michael Lauria, D O’Connell, Katelyn Hasse, Igor Barjaktarević, Percy Lee +3 more
Michael Lauria, Kamal Singhrao, Jonathan Goldin, Igor Barjaktarević, Daniel A. Low +2 more
Kamal Singhrao, Bradley Stiehl, Daniel A. Low, Jonathan Goldin, Igor Barjaktarević +2 more
Hui‐Ming Dong, Yi Lao, Jonathan Pham, Michael Lauria, Fang‐I Chu +9 more
D O’Connell, Michael Lauria, Bradley Stiehl, Louise Naumann, Percy Lee +5 more
E.S. Paulson, X. Allen Li, Bradley A. Erickson, Christopher J. Schultz, Alison Tree +8 more
Dan Ruan, Audrey Dang, Rebecca Levin-Epstein, Ankur Patel, Joanne B. Weidhaas +10 more
Bradley Stiehl, Anand P. Santhanam, D O’Connell, Louise Naumann, Michael F. McNitt‐Gray +5 more
Hao Dong, Yi Lao, Jonathan Pham, M. Lauria, Luca Valle +6 more